Candidate Nomination of Novel Small-Molecule Therapy in Inflammation Triggers Milestone Payment From Janssen Pharmaceuticals, Inc. // Chi-Med
News Archive
Previous Article   |   Next Article
Innovation Platform, RNS Announcements | 9 Oct 2013

Candidate Nomination of Novel Small-Molecule Therapy in Inflammation Triggers Milestone Payment From Janssen Pharmaceuticals, Inc.